共 186 条
[1]
Broers MC(2019)Incidence and Prevalence of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis Neuroepidemiology 52 161-172
[2]
Bunschoten C(2013)Chronic inflammatory demyelinating polyradiculoneuropathy: update on clinical features, phenotypes and treatment options Curr Opin Neurol 26 496-502
[3]
Nieboer D(2001)Clinical spectrum of chronic acquired demyelinating polyneuropathies Muscle Nerve 24 311-324
[4]
Lingsma HF(2009)Recurrences, vaccinations and long-term symptoms in GBS and CIDP J Periph Nerv Syst 14 310-315
[5]
Jacobs BC(2009)Health-related quality-of-life improvements in CIDP with immune globulin IV 10%: the ICE Study Neurology 72 1337-1344
[6]
Eftimov F(2017)Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy J Neurol 264 2481-2486
[7]
van Schaik I(2002)Treatment g: Quality of life complements traditional outcome measures in immune-mediated polyneuropathies Neurology 59 84-91
[8]
Saperstein DS(2019)Chronic inflammatory demyelinating polyneuropathy: update on diagnosis, immunopathogenesis and treatment J Neurol, Neurosurg Psychiatry 90 981-987
[9]
Katz JS(2001)Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy Ann Neurol 50 195-201
[10]
Amato AA(1994)A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy Ann Neurol 36 838-845